Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) has emerged as a major cause of cancer-related death and is the most common type of liver cancer. Due to the current paucity of drugs for HCC therapy there is a pressing need to develop new therapeutic concepts. In recent years, the role of Serum Response Factor (SRF)...
Main Authors: | Constanze Mittermeier, Andreas Konopa, Susanne Muehlich |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/12/2540 |
Similar Items
-
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Controls HCC Growth and Senescence
by: Laura Schreyer, et al.
Published: (2021-10-01) -
Targeting cellular senescence to combat cancer and ageing
by: Chen Wang, et al.
Published: (2022-09-01) -
The Cross Talk between Cellular Senescence and Melanoma: From Molecular Pathogenesis to Target Therapies
by: Jiahua Liu, et al.
Published: (2023-05-01) -
The Interaction of Viruses with the Cellular Senescence Response
by: Rocío Seoane, et al.
Published: (2020-12-01) -
Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs
by: Natalie Kudlova, et al.
Published: (2022-04-01)